PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,486 | -25.5% | 2,086 | 0.0% | 0.00% | – |
Q2 2023 | $7,363 | -93.4% | 2,086 | -94.6% | 0.00% | – |
Q1 2022 | $112,000 | -5.1% | 38,775 | +0.0% | 0.00% | – |
Q4 2021 | $118,000 | -57.6% | 38,771 | -2.1% | 0.00% | – |
Q3 2021 | $278,000 | -22.3% | 39,609 | +1.5% | 0.00% | – |
Q2 2021 | $358,000 | -11.2% | 39,041 | -5.9% | 0.00% | -100.0% |
Q1 2021 | $403,000 | -13.1% | 41,489 | -8.4% | 0.00% | 0.0% |
Q4 2020 | $464,000 | +9.4% | 45,269 | +7.8% | 0.00% | 0.0% |
Q3 2020 | $424,000 | -17.2% | 42,009 | -14.4% | 0.00% | 0.0% |
Q2 2020 | $512,000 | +45.0% | 49,071 | +17.5% | 0.00% | 0.0% |
Q1 2020 | $353,000 | -2.5% | 41,771 | +0.8% | 0.00% | 0.0% |
Q4 2019 | $362,000 | -17.0% | 41,422 | +2.2% | 0.00% | 0.0% |
Q3 2019 | $436,000 | -15.8% | 40,529 | -0.6% | 0.00% | 0.0% |
Q2 2019 | $518,000 | -65.5% | 40,771 | +5.3% | 0.00% | -66.7% |
Q1 2019 | $1,501,000 | +89.5% | 38,705 | -0.6% | 0.00% | +50.0% |
Q4 2018 | $792,000 | -34.9% | 38,938 | +46.6% | 0.00% | 0.0% |
Q3 2018 | $1,217,000 | -27.3% | 26,553 | -6.2% | 0.00% | -33.3% |
Q2 2018 | $1,674,000 | -12.6% | 28,294 | +0.5% | 0.00% | -25.0% |
Q1 2018 | $1,916,000 | -33.3% | 28,161 | -3.1% | 0.00% | -33.3% |
Q4 2017 | $2,872,000 | -31.1% | 29,055 | -16.5% | 0.01% | -33.3% |
Q3 2017 | $4,167,000 | +41.4% | 34,794 | +3.1% | 0.01% | +28.6% |
Q2 2017 | $2,948,000 | +136.8% | 33,733 | +0.8% | 0.01% | +133.3% |
Q1 2017 | $1,245,000 | +26.7% | 33,462 | +4.5% | 0.00% | +50.0% |
Q4 2016 | $983,000 | -46.0% | 32,033 | +18.0% | 0.00% | -60.0% |
Q3 2016 | $1,821,000 | +123.4% | 27,152 | -0.8% | 0.01% | +150.0% |
Q2 2016 | $815,000 | +18.3% | 27,358 | +16.7% | 0.00% | 0.0% |
Q1 2016 | $689,000 | -63.8% | 23,451 | -3.4% | 0.00% | -66.7% |
Q4 2015 | $1,904,000 | +2.9% | 24,283 | -1.1% | 0.01% | 0.0% |
Q3 2015 | $1,851,000 | -36.7% | 24,557 | -2.0% | 0.01% | -33.3% |
Q2 2015 | $2,925,000 | -51.0% | 25,054 | -0.9% | 0.01% | -47.1% |
Q1 2015 | $5,971,000 | +45.9% | 25,289 | +17.0% | 0.02% | +41.7% |
Q4 2014 | $4,093,000 | -22.2% | 21,623 | -1.9% | 0.01% | -25.0% |
Q3 2014 | $5,260,000 | +268.9% | 22,048 | +2.1% | 0.02% | +300.0% |
Q2 2014 | $1,426,000 | -35.0% | 21,604 | +2.5% | 0.00% | -42.9% |
Q1 2014 | $2,194,000 | -3.3% | 21,067 | -3.9% | 0.01% | 0.0% |
Q4 2013 | $2,270,000 | +99.8% | 21,924 | +3.5% | 0.01% | +75.0% |
Q3 2013 | $1,136,000 | +32.2% | 21,174 | +9.4% | 0.00% | +33.3% |
Q2 2013 | $859,000 | – | 19,350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
Eversept Partners, LP | 58,251 | $491,638 | 0.12% |